1. Home
  2. JXN vs RYTM Comparison

JXN vs RYTM Comparison

Compare JXN & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jackson Financial Inc.

JXN

Jackson Financial Inc.

HOLD

Current Price

$113.66

Market Cap

6.5B

Sector

Finance

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$102.21

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JXN
RYTM
Founded
1961
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.4B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
JXN
RYTM
Price
$113.66
$102.21
Analyst Decision
Hold
Strong Buy
Analyst Count
5
13
Target Price
$108.80
$128.54
AVG Volume (30 Days)
465.3K
658.3K
Earning Date
02-18-2026
02-25-2026
Dividend Yield
2.82%
N/A
EPS Growth
N/A
N/A
EPS
7.31
N/A
Revenue
$4,997,000,000.00
$174,334,000.00
Revenue This Year
$113.97
$47.34
Revenue Next Year
$6.08
$55.95
P/E Ratio
$15.54
N/A
Revenue Growth
25.33
54.92
52 Week Low
$64.70
$45.91
52 Week High
$118.18
$122.20

Technical Indicators

Market Signals
Indicator
JXN
RYTM
Relative Strength Index (RSI) 62.66 45.21
Support Level $112.41 $96.20
Resistance Level $118.18 $114.00
Average True Range (ATR) 2.67 5.41
MACD -0.14 -0.06
Stochastic Oscillator 64.70 33.31

Price Performance

Historical Comparison
JXN
RYTM

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: